Please assess the completion status of the following clinical trial:

Trial Title: Electronic Deprescribing Tool for the Prevention of PIP

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients ≥65 years who have been taking Benzodiazepines or/and Non-benzodiazepine hypnotics for at least 3 months and who do not meet any exclusion criterion~Exclusion Criteria:~* incapacity or unwillingness to provide written informed consent. Patient with dementia, psychotic disorder, a severe personality disorder; institutionalization; terminal illness, seizure disorders, rapid eye movement sleep disorders, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, epilepsy and periprocedural anesthesia

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Electronic Deprescribing tool (Type: EXPERIMENTAL): GPs of enrolled patients with access to the electronic Deprescribing tool
- Usual Care (Type: NO_INTERVENTION): Usual care By GP´s

Based on this trial design, predict the completion outcome and termination type (if applicable).